Structured evidence table for Chromium Supplementation Blood Sugar Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chromium Supplementation Blood Sugar Meta-Analysis | Chromium supplementation has been associated with encouraging improvements in insulin sensitivity. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Supplementation Blood Sugar Meta-Analysis | This comprehensive review delves into the implications of chromium supplementation, particularly chromodulin, in the context of MetS and its associated pathological sequelae. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Supplementation Blood Sugar Meta-Analysis | In conclusion, chromium (Cr) enhances insulin sensitivity by directly activating the insulin receptor kinase, which lowers the required insulin concentration for maximal cellular response and improves glucose uptake and storage. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Supplementation Blood Sugar Meta-Analysis | Metabolic syndrome (MetS) is a complex interplay of interrelated metabolic derangements, including insulin resistance, dyslipidemia, central adiposity, and hypertension, thereby markedly amplifying the predisposition to type 2 diabetes mellitus (T2DM) and cardiovascular morbidities. | 1 | Babakr AT (2026) | Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes. |
| Chromium Supplementation Blood Sugar Meta-Analysis | Reduced insulin receptor sensitivity leads to a significant decline in insulin efficacy during glucose metabolism, further promoting hyperinsulinemia. | 1 | Ye Jiahui (2026) | Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials |
| Chromium Supplementation Blood Sugar Meta-Analysis | [] reported that chromium may improve IR, while other studies have found that mineral supplements have no significant effects on blood sugar, lipids, or PCOS []. | 1 | Ye Jiahui (2026) | Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials |
| Chromium Supplementation Blood Sugar Meta-Analysis | [] conducted a case-control study showing that reduced serum zinc concentrations in women with PCOS positively impact metabolic and endocrine systems. | 1 | Ye Jiahui (2026) | Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials |
| Chromium Supplementation Blood Sugar Meta-Analysis | 1 2 3 4 5 6 7 8 9 10 11 12 Polycystic ovary syndrome (PCOS) is a prevalent public health concern and one of the most commonly occurring endocrine disorders []. | 1 | Ye Jiahui (2026) | Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials |
Source documents